CardioNerds HCM Knowledge Hub

Welcome to the Hypertrophic Cardiomyopathy (HCM) Knowledge Hub powered by CardioNerds. We deliver key insights and unique perspectives through podcasts, articles, videos and more—all uniquely created by cardiologists to inform and educate.

84. Case Report: Hypertrophic Cardiomyopathy with Superimposed Stress Cardiomyopathy – Brown University

CardioNerdsHypertrophic Cardiomyopathy | April 28, 2023

CardioNerds (Amit Goyal & Daniel Ambinder) join Brown University cardiology fellows (Greg Salber, Vrinda Trivedi, ...

FDA Approves Mavcamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy

Devesh Rai, MDHypertrophic Cardiomyopathy | June 28, 2023

The United States Food and Drug Administration (FDA) approved Mavacamten to treat patients with symptomatic obstructive ...

68. Case Report: WPW and HCM Phenotype – VCU

CardioNerdsHypertrophic Cardiomyopathy | April 28, 2023

CardioNerds (Amit Goyal & Daniel Ambinder) join Virginia Commonwealth University (VCU) cardiology fellows (Ajay ...

6. Hypertrophic Cardiomyopathy Surgical & Transcatheter Septal Reduction Therapies with Drs. Amar Krishnaswamy and Per Wierup

CardioNerdsHypertrophic Cardiomyopathy | April 28, 2023

Amit joins Dr. Laura Young to take a pulse check with these great experts.

5. Hypertrophic Cardiomyopathy Historical Perspective with Dr. Edward Kasper

CardioNerdsHypertrophic Cardiomyopathy | April 28, 2023

Dr. Edward Kasper shares a unique historical perspective on how the field evolved as medicine learned more about HCM.

The VALOR-HCM Trial: Encouraging Findings for Patients with Obstructive HCM

CardioNerdsHypertrophic Cardiomyopathy | May 2, 2023

In this insightful interview, Rawan Amir, MBBS, and CardioNerds Academy Fellow, spoke with Milind Desai, MD, MBA, ...

The Digital Diagnostician: Deep Learning to Detect HCM vs. Amyloidosis

Hirsh ElhenceHypertrophic Cardiomyopathy | May 2, 2023

As novel therapeutic agents such as Mavacamten and Tafamidis are developed and become clinically useful for patients ...

VALOR-HCM: Mavacamten Decreases Need for Septal Reduction Therapy in Symptomatic Obstructive HCM

CardioNerdsHypertrophic Cardiomyopathy | May 2, 2023

New pharmacological agent reduces need for septal reduction therapy in patients with symptomatic obstructive ...

Artificial Intelligence Based ECG Scores Can Predict Response to Treatment in Hypertrophic Obstructive, Is This the Future?

Devesh Rai, MDHypertrophic Cardiomyopathy | May 2, 2023

Historically, early detection of hypertrophic cardiomyopathy (HCM) has been challenging, and prior artificial ...

4. Practical Approach to HCM with Dr. Jose Madrazo

CardioNerdsHypertrophic Cardiomyopathy | April 28, 2023

Clinical and echo expert Dr. Jose Madrazo discusses a high yield and practical approach to diagnose HCM.

3. Hypertrophic Cardiomyopathy: Case Discussion

CardioNerdsHypertrophic Cardiomyopathy | April 28, 2023

Dr. Fatimah Alkhunaizi and the CardioNerds discuss pathophysiology, diagnosis, imaging, and management of HCM.

166. CardioNerds Rounds: Challenging Cases of Hypertrophic Cardiomyopathy with Dr. Michelle Kittleson

CardioNerdsHypertrophic Cardiomyopathy | June 14, 2023

CardioNerds Rounds Co-Chair, Dr. Karan Desai, joins Dr. Michelle Kittleson to discuss hypertrophic cardiomyopathy.

Podcast 118. The Braunwald Chronicles: A “Royal Screw-up” & The Discovery of Hypertrophic Cardiomyopathy

CardioNerdsHypertrophic Cardiomyopathy | May 2, 2023

CardioNerds (Amit Goyal, Daniel Ambinder, Carine Hamo, and Karan Desai) are honored to bring to you the Braunwald ...